☰

Timothy D. Wiltshire, Ph.D. - Publications

Affiliations: 
2007 West Virginia University, Morgantown, WV, United States 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Singh N, Basnet H, Wiltshire TD, Mohammad DH, Thompson JR, Héroux A, Botuyan MV, Yaffe MB, Couch FJ, Rosenfeld MG, Mer G. Dual recognition of phosphoserine and phosphotyrosine in histone variant H2A.X by DNA damage response protein MCPH1. Proceedings of the National Academy of Sciences of the United States of America. 109: 14381-6. PMID 22908299 DOI: 10.1073/Pnas.1212366109  0.387
2012 Singh N, Wiltshire TD, Thompson JR, Mer G, Couch FJ. Molecular basis for the association of microcephalin (MCPH1) protein with the cell division cycle protein 27 (Cdc27) subunit of the anaphase-promoting complex. The Journal of Biological Chemistry. 287: 2854-62. PMID 22139841 DOI: 10.1074/Jbc.M111.307868  0.338
2010 Wiltshire TD, Lovejoy CA, Wang T, Xia F, O'Connor MJ, Cortez D. Sensitivity to poly(ADP-ribose) polymerase (PARP) inhibition identifies ubiquitin-specific peptidase 11 (USP11) as a regulator of DNA double-strand break repair. The Journal of Biological Chemistry. 285: 14565-71. PMID 20233726 DOI: 10.1074/Jbc.M110.104745  0.609
2007 Wiltshire T, Senft J, Wang Y, Konat GW, Wenger SL, Reed E, Wang W. BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven. Molecular Pharmacology. 71: 1051-60. PMID 17229870 DOI: 10.1124/Mol.106.029504  0.623
2007 Wang Y, Wiltshire T, Senft J, Reed E, Wang W. Irofulven induces replication-dependent CHK2 activation related to p53 status. Biochemical Pharmacology. 73: 469-80. PMID 17118344 DOI: 10.1016/J.Bcp.2006.10.023  0.62
2006 Wang Y, Wiltshire T, Senft J, Wenger SL, Reed E, Wang W. Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven. Molecular Cancer Therapeutics. 5: 3153-61. PMID 17172419 DOI: 10.1158/1535-7163.Mct-06-0427  0.607
2004 Wang J, Wiltshire T, Wang Y, Mikell C, Burks J, Cunningham C, Van Laar ES, Waters SJ, Reed E, Wang W. ATM-dependent CHK2 activation induced by anticancer agent, irofulven. The Journal of Biological Chemistry. 279: 39584-92. PMID 15269203 DOI: 10.1074/Jbc.M400015200  0.583
Show low-probability matches.